South Korea Allows In Vitro Test Data for SPF and PA Labeling and Advertising Substantiation
Published: Author:

On November 10, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea issued Notice No. 2026-76, partially amending the Regulation on Substantiation of Cosmetics Labeling and Advertising.

This revision clarifies that when business operators or sellers make labeling and advertising claims concerning the sun protection factor (SPF) and the protection grade of UVA (PA), the claims must be substantiated by data demonstrating the corresponding function in functional cosmetics; in addition to the human application test data that were previously the only accepted data type, internationally recognized in vitro test data are now also included within the scope of acceptance. This revision has taken effect on November 10, 2027.

Background

Under the current regulation, only human application test data were accepted as the substantiating data for the SPF and PA labeling and advertising claims of sunscreen products.

To ensure the quality of cosmetics and promote international harmonization, this revision newly adds internationally recognized in vitro test data, so that SPF- and PA-related labeling and advertising claims can be substantiated by either human application test data or in vitro test data.

Substantiating Data Requirements Corresponding to Labeling and Advertising Claims

According to the revised attached table, the following labeling and advertising claims must comply with the corresponding substantiating data requirements:

  • Suitable for acne-prone skin: human application test data
  • Antibacterial (limited to products for cleansing the human body): human application test data
  • Alleviating skin aging: human application test data or in vitro test data
  • Temporarily reducing cellulite: human application test data
  • Alleviating swelling and dark circles: human application test data
  • Improving skin blood circulation: human application test data
  • Increasing, decreasing, or activating collagen: data demonstrating the corresponding function in functional cosmetics
  • Increasing, decreasing, or activating enzymes: data demonstrating the corresponding function in functional cosmetics
  • Sun protection factor (SPF), water-resistant sun protection factor (SPF, water resistance or persistent water resistance), and protection grade of UVA (PA): data demonstrating the corresponding function in functional cosmetics

Effective Date and Scope of Application

  • Effective date: This Notice will take effect one year after its promulgation (i.e., from November 10, 2027).
  • Scope of application: After this Notice takes effect, the requirements apply to items that undergo functional cosmetics review (including changes) or submit reports.

CIRS Reminder

The adjustment of the substantiating data for SPF and PA labeling and advertising directly concerns the claim management of sunscreen products in the South Korean market. CIRS Group recommends that relevant enterprises:

  • Enterprises exporting sunscreen products to South Korea should continue to prepare SPF and PA substantiating data as human application test data under the current requirements before the new requirements take effect; after they take effect, enterprises may choose a feasible verification path between human application tests and in vitro tests in accordance with the specific requirements of the Regulations on the Review of Functional Cosmetics, and coordinate test cycles and costs holistically;
  • Note that the timing of application is delineated by “review (including changes) or report submission”: the new requirements apply only to items that undergo functional cosmetics review or submit reports after the new requirements take effect; products already on the market are not subject to retroactive application, but those involving re-review or report submission due to efficacy changes must prepare substantiating data under the new requirements;
  • Where in vitro test data are used, the tests must adopt scientifically validated methods or standard operating procedures established through validation, and meet requirements such as testing institution qualifications and the final test result report.

What Can CIRS Do for You?

Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan, and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services, from regulatory compliance, laboratory testing, and R&D to data services across multiple industries. 

The CIRS cosmetic team provides expert support to ensure that cosmetic products meet stringent global cosmetic regulations and safety standards. We offer comprehensive, lifecycle-based solutions for personal care products, from early-stage cosmetic ingredient development through to final product registration. Our services include:

With deep expertise in cosmetic regulatory compliance and safety evaluations, our team enables brands to bring products to market efficiently and with confidence.

Our Services

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

South Korea KCIA

Disclaimer :
CIRS accepts no responsibility or liability whatsoever with regard to the information on this website. Reproduction for non-commercial purposes of information and documents from the our website is authorised provided that you acknowledge "CIRS" as the source.